The secreted isoform of aSMase is directly implicated in the pathogenesis of atherosclerosis, as it has been demonstrated that its release can be promoted by atherogenic proinflammatory cytokines and its activity increases ceramide levels by hydrolysis of SM on lipoprotein particles [53]. Here, SMPD1 is linked to atherosclerosis.